Close Menu

NEW YORK – Vancouver, British Columbia-based molecular diagnostics maker Fusion Genomics announced Thursday it has been awarded a one-year, $1 million grant from a Canadian research consortium. The funds will support a prospective clinical study using the firm's OneTest next-generation sequencing-based platform to diagnose respiratory tract infections.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.